Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024)

Historic Other Operating Expenses for Arcus Biosciences (RCUS) over the last 2 years, with Q1 2024 value amounting to $20.0 million.

  • Arcus Biosciences' Other Operating Expenses changed N/A to $20.0 million in Q1 2024 from the same period last year, while for Dec 2024 it was $20.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2024, which is N/A changed from last year.
  • Arcus Biosciences' Other Operating Expenses amounted to $20.0 million in Q1 2024.
  • Arcus Biosciences' Other Operating Expenses' 5-year high stood at $20.0 million during Q1 2024, with a 5-year trough of -$248000.0 in Q4 2020.